Release Date: 05/03/13 19:55 Summary: Lapse and Issue of Options Price Sensitive: No Download Document 1.16MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%